Dystrophy Myotonic
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Global Study of Del-desiran for the Treatment of DM1 (NCT06411288) | Avidity Biosciences, Inc. | 2024-05-30 |
| Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients (NCT05027269) | Avidity Biosciences, Inc. | 2021-10-28 |
Track Dystrophy Myotonic automatically
Every clearance here is in the API, with alerts when new ones post.